News

  • Curaleaf Opens Two New Florida Dispensaries in Pembroke Park and Englewood

Florida’s Amendment 3 Sets Record for Cannabis Legislation Funding

LOS ANGELES- Amendment 3, a measure to legalize recreational cannabis for adults 21 and over, is on Florida's ballot this November. The campaign, led by Smart & Safe Florida, has become the most expensive cannabis legalization effort in U.S. history, drawing more than $105 million in contributions. Notably, the state's largest medical cannabis company, Trulieve, ...

September 24th, 2024|Justice|

Week’s In Review: South Carolina AG Confirms Legality of Hemp-Derived THC Beverages; COMPASS Pathways Receives Analyst Ratings; Pennsylvania Lawmakers Introduce Bipartisan Bill to Legalize Recreational Cannabis.

LOS ANGELES–Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's get to it! Cannabis Industry Highlights 1#South Carolina AG Confirms Legality of Hemp-Derived THC Beverages: South Carolina Solicitor General Robert ...

September 23rd, 2024|Business, The Week in Review|

Ontario Leads Canadian Cannabis Sales

LOS ANGELES- Canada's legal cannabis market continues to show strong performance, with sales exceeding $2.4 billion in the first half of 2024, according to data from Statistics Canada. The provinces driving these numbers were Ontario, Alberta, and Quebec, contributing $934.6 million, $440 million, and $343.1 million, respectively. This surge in sales is in line with ...

September 23rd, 2024|Capital|

Georgia Pharmacy Defies Federal Ban, Sells Low-THC Cannabis Products

LOS ANGELES- A licensed pharmacy in Augusta, Georgia, has begun selling low-THC cannabis products, directly challenging federal regulations enforced by the U.S. Drug Enforcement Administration (DEA). Living Well Pharmacy, owned by Vic Johnson, is one of the 40 pharmacies approved under Georgia's 2019 medical marijuana law to dispense cannabis with a THC content of 5% ...

September 23rd, 2024|Insights|

Critical Factors for Optimizing the Employee Lifecycle in Cannabis Businesses

LOS ANGELES — The cannabis industry is rapidly growing, fueled by increasing legalization and broader societal acceptance. With this growth comes a unique set of challenges, especially in the realm of human resources. For cannabis businesses, managing the employee lifecycle—from hiring to retirement—requires not only adherence to complex regulations when it comes to their employees, ...

September 20th, 2024|Business, Insights|

South Carolina AG Confirms Legality of Hemp-Derived THC Beverages

LOS ANGELES- South Carolina Solicitor General Robert D. Cook issued a legal opinion on Sept. 16, affirming that nonalcoholic beverages containing hemp-derived delta-9 THC are legal under the 2018 Farm Bill, provided they contain no more than 0.3% THC by dry weight. The opinion was in response to a request from South Carolina House Speaker ...

September 20th, 2024|Insights|

Pennsylvania Lawmakers Introduce Bipartisan Bill to Legalize Recreational Cannabis

LOS ANGELES- A bipartisan group of Pennsylvania lawmakers introduced a bill last week to legalize recreational cannabis for adults. The legislation, known as House Bill 2500, was sponsored by Republican Rep. Aaron Kaufer and Democratic Rep. Emily Kinkead, with 15 additional cosponsors. If passed, it would legalize cannabis for adults over the age of 21 ...

September 19th, 2024|Justice|

Psyence Biomed Advances Clinical Trials in Psilocybin for Mental Health Treatments

LOS ANGELES- Psyence Biomedical Ltd. a life science biotechnology company focused on natural psychedelics for mental health, has issued updates on its progress in clinical research and corporate development. The company is leading efforts to develop natural psilocybin products for palliative care, with a focus on addressing psychological trauma and mental health challenges. Psyence is ...

September 19th, 2024|Psychedelics|

COMPASS Pathways Receives Analyst Ratings

LOS ANGELES- COMPASS Pathways, a company specializing in mental health treatments, has garnered significant attention in recent market reports due to favorable analyst ratings and its stock performance. Several brokerages have maintained a consensus "Buy" rating on COMPASS Pathways, with price targets ranging from $23.00 to $47.40. Six research analysts have recently reiterated their "buy" ...

September 18th, 2024|Insights|

Verano Holdings to Participate in Key Investor Conferences

LOS ANGELES- Verano Holdings Corp. U.S. multi-state cannabis company, has announced its participation in two significant industry conferences. The company’s executives will engage with investors and industry leaders to discuss important market developments and future outlooks for the cannabis sector. On September 18, 2024, Verano’s Chief Investment Officer, Aaron Miles, will join investor meetings and ...

September 18th, 2024|Capital|

High Tide Inc. Reports Revenue and Profitability in Q3 2024

LOS ANGELES- High Tide Inc. reported strong financial results for the third fiscal quarter of 2024, with record revenue of $131.7 million, reflecting a 6% increase year-over-year and sequentially. This revenue growth underscores the company's success in expanding its market share and navigating the competitive cannabis sector. The company's gross profit reached $35.5 million, a ...

September 17th, 2024|Insights|

MediPharm Labs Achieves Debt-Free Status with $2.1M Repayment

LOS ANGELES- MediPharm Labs Corp., a pharmaceutical company specializing in cannabis-based health products, has announced the repayment of its remaining $2.1 million convertible debt, making the company materially debt-free. With over $13 million in cash reserves and full ownership of three facilities, MediPharm now holds a strong financial position. The company reported an adjusted EBITDA ...

September 17th, 2024|Capital|

Silo Pharma Advances Regulatory Path for PTSD Treatment SPC-15

LOS ANGELES- Silo Pharma, Inc. a developmental stage biopharmaceutical company, has submitted a proposal for FDA approval of its PTSD treatment, SPC-15, through the 505(b)(2) regulatory pathway. This pathway is designed to shorten clinical timelines and reduce development costs. The company recently completed a pre-Investigational New Drug (pre-IND) meeting with the FDA, receiving feedback to ...

September 17th, 2024|Psychedelics|

Emerald Cup 2024: Behind the Scenes at a Celebration of Cannabis Culture in Oakland

OAKLAND — Last month, the Emerald Cup 2024, a premier event in the cannabis community, took place at the historic Henry J. Kaiser Convention Center in Oakland. Celebrating its 20th anniversary, this iconic event honors cannabis culture, advocacy, and innovation against a backdrop rich in history, having hosted legendary performances by The Doors and The ...

September 16th, 2024|Business, News|

Michigan Cannabis Sales Hit Record $295.4 Million in August

LOS ANGELES- Michigan's cannabis industry set a new monthly sales record in August, with licensed dispensaries generating $295.4 million in revenue, according to the state's Cannabis Regulatory Agency (CRA). This figure includes $294.1 million from adult-use sales and nearly $1.3 million from medical cannabis. The record surpasses the previous high of $288.8 million set in ...

September 16th, 2024|Capital|

Nixon’s Secret Recordings: A Shift in Private Views on Cannabis

LOS ANGELES- Recently uncovered White House recordings from 1973 reveal that President Richard Nixon privately acknowledged that cannabis was "not particularly dangerous," a stance at odds with his administration's aggressive drug policies. The recordings, discovered by drug reform advocate Kurtis Hanna while reviewing the Nixon Library archives, show a more nuanced perspective on cannabis than ...

September 16th, 2024|Insights|

Week’s In Review: Green Thumb Secures $150 Million Syndicated Credit Facility; FDA Consideration of Psilocybin Therapy Could Impact Millions of Depression Patients; Cannabis Sector Volatility Deepens After DEA Rescheduling Delay

LOS ANGELES–Welcome to the far too-exciting world of cannabis and psychedelics, where it’s a tale of two markets with some states doing amazingly well. And some, well...they're not doing so well (hello New York). Let's get to it! Cannabis Industry Highlights 1#Green Thumb Secures $150 Million Syndicated Credit Facility: Green Thumb Industries Inc, a national ...

September 16th, 2024|Business, The Week in Review|

Urbana Breathes New Life into Historic Luka’s Taproom with a New Cannabis Dispensary and Lounge in Oakland

Honoring a Beloved Oakland Landmark, Urbana Introduces a New Paradigm in Cannabis Retail and Consumption OAKLAND, CA – Urbana, one of Northern California’s premier cannabis brands, is thrilled to announce the opening of its newest dispensary and consumption lounge in the heart of Oakland. Located in the historic Luka’s Taproom, Urbana’s newest site pays tribute ...

September 16th, 2024|Brands, Business, News|

Dispensary vs. Experience: Retail Models Disrupting the Cannabis Consumer Journey

LOS ANGELES — Cannabis retail is undergoing a significant transformation, moving beyond traditional dispensary models to offer more immersive and meaningful customer experiences, represented in the rising introduction of consumption lounges.  Companies like NorCal's Urbana are at the forefront of this shift, demonstrating how to deeply connect with a diverse consumer base.  Insights from Urbana's ...

September 13th, 2024|Business, Insights, News|

FDA Consideration of Psilocybin Therapy Could Impact Millions of Depression Patients

LOS ANGELES- Recent research suggests that the active ingredient in psychedelic mushrooms, psilocybin, may offer significant benefits for individuals struggling with depression, pending approval from the U.S. Food and Drug Administration (FDA). With roughly one in 10 American adults experiencing depressive illness annually, the potential for psilocybin therapy to alleviate symptoms has garnered increasing attention. ...

September 13th, 2024|Psychedelics|

California Governor Proposes Emergency Ban on THC in Hemp Products

LOS ANGELES- California Governor Gavin Newsom announced emergency regulations on Friday that would prohibit the sale of hemp products containing detectable levels of THC, the psychoactive compound in cannabis. The move aims to address concerns over the availability of intoxicating hemp products, especially those accessible to minors. Hemp products are currently sold outside of regulated ...

September 13th, 2024|Insights|

Medical Cannabis in Germany: A Gateway for Investment and Innovation

The investment climate in Germany's medical cannabis industry is poised for significant expansion, driven by the global cannabis legalization movement, ongoing regulatory changes, and mounting community and market demand. As the country embraces a more liberal approach to cannabis, it is becoming an increasingly appealing destination for investors and businesses in the medical cannabis sector. ...

September 12th, 2024|Business, Insights, World|

MindMed to Present at Key September Investor Conferences

LOS ANGELES- Mind Medicine (MindMed) Inc., a clinical-stage biopharmaceutical company focused on developing novel treatments for brain health disorders, announced its participation in three significant investor conferences in September 2024. MindMed’s management team will engage in discussions on the evolving role of psychedelics in psychiatry and brain health treatments. The company’s schedule includes: A panel ...

September 12th, 2024|Psychedelics|

Green Thumb Secures $150 Million Syndicated Credit Facility

LOS ANGELES- Green Thumb Industries Inc, a national cannabis consumer packaged goods company and owner of RISE Dispensaries, has announced the closing of a $150 million 5-year syndicated credit facility. The financing, led by Valley National Bank, marks a significant development in the U.S. cannabis industry, as it is the first such arrangement for the ...

September 12th, 2024|Business|
Go to Top